top of page

DOLOMITE - Safety and effectiveness of DTG use in pregnancy
A multi-site observational study to define the safety and effectiveness of Dolutegravir use in HIV positive pregnant women
Indication: HIV positive women receiving DTG (at least 200 starting or on DTG in the first trimester)
Phase: IV
Countries: UK, spain, Portugal, France, Italy, Belgium, Poland & Ukraine
Sites: 21 & Counting
Status: Actively recruiting
bottom of page